146
Views
0
CrossRef citations to date
0
Altmetric
Review

Using lymphoscintigraphy as a prognostic tool in patients with cancer

&
Pages 1-17 | Published online: 15 Apr 2016

References

  • Sherman AI, Ter-Pogossian M. Lymph node concentration of radioactive colloidal gold following interstitial injection. Cancer. 1953;6(6):1238–1240.
  • Hayes S, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology. 2008;41(1):18–28.
  • Kramer EL. Lymphoscintigraphy: defining a clinical role. Lymphat Res Biol. 2001;2(1):32–37.
  • Hwang JH, Choi JY, Lee JY, et al. Lymphoscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema. Lymphology. 2007;40(4):172–176.
  • Hellman S. Karnofsky memorial lecture. Natural history of small breast cancers. J Clin Oncol. 1994;12(10):2229–2234.
  • Kazem I, Brady LW, Croll MN, Faust DS, Wolferth CC. The parasternal lymph-node scan as a prognostic test in breast carcinoma. Radiology. 1969;92(3):617–620.
  • Xiong L, Engel H, Gazyakan E, et al. Current techniques for lymphatic imaging: state of the art and future perspectives. Eur J Surg Oncol. 2014;40(3):270–276.
  • Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59(4):464–472.
  • Schook CC, Mulliken JB, Fishman SJ, Grant FD, Zurakowski D, Greene AK. Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg. 2011;127(6):2419–2431.
  • Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg. 2004;187(1):69–72.
  • Hinrichs CS, Watroba NL, Rezaishiraz H, et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol. 2004;11(6):573–580.
  • Ohba Y, Todo Y, Kobayashi N, et al. Risk factors for lower-limb lymphedema after surgery for cervical cancer. Int J Clin Oncol. 2011;16(3):238–243.
  • Tiwari A, Cheng KS, Button M, Myint F, Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg. 2003;138(2):152–161.
  • Stanton AW, Modi S, Mellor RH, Levick JR, Mortimer PS. Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat Res Biol. 2009;7(1):29–45.
  • McLaughlin SA. Lymphedema: separating fact from fiction. Oncology. 2012;26(3):242–249.
  • Wojcinski S, Nuengsrl S, Hillemanns P, et al. Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity. Cancer Manag Res. 2012;4:121–127.
  • Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44(1):43–57.
  • Williams WH, Witte CL, Witte MH, McNeill GC. Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clin Nucl Med. 2000;25(6):451–464.
  • Szuba A, Strauss W, Sirsikar SP, Rockson SG. Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity. Nucl Med Commun. 2002;23(12):1171–1175.
  • Kim YB, Hwang JH, Kim TW, Chang HJ, Lee SG. Would complex decongestive therapy reveal long term effect and lymphoscintigraphy predict the outcome of lower-limb lymphedema related to gynecologic cancer treatment? Gynecol Oncol. 2012;127(3):638–642.
  • Pecking AP, Albérini JL, Wartski M, Edeline V, Cluzan RV. Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging. Lymphology. 2008;41(1):1–10.
  • Giammarile F, Alazraki N, Aarsvold JN, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40(12):1932–1947.
  • Hung JC, Wiseman GA, Wahner HW, Mullan BP, Taggart TR, Dunn WL. Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. J Nucl Med. 1995;36(10):1895–1901.
  • Mostbeck A, Partsch H. Isotope lymphography: possibilities and limits in evaluation of lymph transport. Wien Med Wochenschr. 1999;149(2–4):87–91.
  • Partsch H. Assessment of abnormal lymph drainage for the diagnosis of lymphedema by isotopic lymphangiography and by indirect lymphography. Clin Dermatol. 1995;13(5):445–450.
  • Erba PA, Solllini M, D’Errico G, Mariani G. Methodological aspects of lymphoscintigraphy: bicompartimental versus monocompartimental radiocolloid administration. In: Mariani G, Manca G, Valdés AR, Orsini F, Vidal-Sicart S, editors. Atlas of Lymphoscintigraphy and Sentinel Node Mapping. A Pictorial Case-Based Approach. Milan: Springer-Verlag Milan; 2013:27–38.
  • Bräutigam P, Földi E, Schaiper I, Krause T, Vanscheidt W, Moser E. Analysis of lymphatic drainage in various forms of leg edema using two compartment lymphoscintigraphy. Lymphology. 1998;31(2):43–55.
  • Karaçavuş S, Yilmaz YK, Ekim H. Clinical significance of lymphoscintigraphy findings in the evaluation of lower extremity lymphedema. Mol Imaging Radionucl Ther. 2015;24(2):80–84.
  • Moshiri M, Katz DS, Boris M, Yung E. Using lymphoscintigraphy to evaluate suspected lymphedema of the extremities. AJR Am J Roentgenol. 2002;178(2):405–412.
  • Infante JR, García L, Laguna P, et al. Lymphoscintigraphy for differential diagnosis of peripheral edema: diagnostic yield of different scintigraphic patterns. Rev Esp Med Nucl Imagen Mol. 2012;31(5):237–242.
  • Bourgeois P, Leduc O, Belgrado JP, Leduc A. Scintigraphic investigations of the superficial lymphatic system: quantitative differences between intradermal and subcutaneous injections. Nucl Med Commun. 2009;30(4):270–274.
  • Tartaglione G, Pagan M, Morese R, et al. Intradermal lymphoscintigraphy at rest and after exercise: a new technique for the functional assessment of the lymphatic system in patients with lymphoedema. Nucl Med Commun. 2010;31(6):547–551.
  • Carena M, Campini R, Zelaschi G, Rossi G, Aprile C, Paroni G. Quantitative lymphoscintigraphy. Eur J Nucl Med. 1988;14(2):88–92.
  • Dabrowski J, Merkert R, Kuśmierek J. Optimized lymphoscintigraphy and diagnostics of lymphatic oedema of the lower extremities. Nucl Med Rev Cent East Eur. 2008;11(1):26–29.
  • Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology. 1988;167(3):729–735.
  • Scarsbrook AF, Ganeshan A, Bradley KM. Pearls and pitfalls of radionuclide imaging of the lymphatic system part 2: evaluation of extremity lymphoedema. Br J Radiol. 2007;80(951):219–226.
  • Stanton AW, Modi S, Mellor RH, et al. A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment. Clin Sci (Lond). 2006;110(5):553–561.
  • Gironet N, Baulieu F, Giraudeau B, et al. [Lymphedema of the limb: predictors of efficacy of combined physical therapy]. Ann Dermatol Venereol. 2004;131(8–9):775–779.
  • Slavin SA, Upton J, Kaplan WD, Van den Abbeele AD. An investigation of lymphatic function following free-tissue transfer. Plast Reconstr Surg. 1997;99(3):730–741.
  • Weiss M, Baumeister RG, Hahn K. Planning and monitoring of autologous lymph vessel transplantation by means of nuclear medicine lymphoscintigraphy. Handchir Mikrochir Plast Chir. 2003;35(4):210–215.
  • Frühling JG, Bourgeois P. Axillary lymphoscintigraphy: current status in the treatment of breast cancer. Crit Rev Oncol Hematol. 1983;1(1):1–20.
  • Das IJ, Cheville AL, Scheuermann J, Srinivas SM, Alavi A, Solin LJ. Use of lymphoscintigraphy in radiation treatment of primary breast cancer in the context of lymphedema risk reduction. Radiother Oncol. 2011;100(2):293–298.
  • Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39(2):456–466.
  • Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–399.
  • Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17(3):976–983.
  • McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18(13):2560–2566.
  • Kitajima M, Kitagawa Y. Universal applications of sentinel node technology. Ann Surg Oncol. 2004;11(3 Suppl):144S–146S.
  • Nieweg OE, Uren RF, Thompson JF. The history of sentinel lymph node biopsy. Cancer J. 2015;21(1):3–6.
  • Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med. 1993;34(9):1435–1440.
  • O’Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg. 1995;170(5):461–466.
  • Kamath D, Rapaport D, DeConti R, et al. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc. 1997;84(3):182–187.
  • Valdés Olmos RA, Hoefnagel CA, Nieweg OE, et al. Lymphoscintigraphy in oncology: a rediscovered challenge. Eur J Nucl Med. 1999;26(4 Suppl):S2–S10.
  • Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, Aarsvold JN. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. Semin Nucl Med. 2000;30(1):56–64.
  • Paganelli G, De Cicco C, Chinol M. Sentinel node localization by lymphoscintigraphy: a reliable technique with widespread applications. Recent Results Cancer Res. 2000;157:121–129.
  • Bluemel C, Herrmann K, Giammarile F, et al. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging. 2015;42(11):1750–1766.
  • Moncayo VM, Aarsvold JN, Alazraki NP. Lymphoscintigraphy and sentinel nodes. J Nucl Med. 2015;56(6):901–907.
  • Taylor A Jr, Murray D, Herda S, Vansant J, Alazraki N. Dynamic lymphoscintigraphy to identify the sentinel and satellite nodes. Clin Nucl Med. 1996;21(10):755–758.
  • Uren RF, Howman-Giles RB, Thompson JF. Variation in cutaneous lymphatic flow rates. Ann Surg Oncol. 1997;4(3):279–280.
  • Kapteijn BA, Nieweg OE, Valdés Olmos RA, et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med. 1996;37(6):972–975.
  • Tonakie A, Sondak V, Yahanda A, Wahl RL. Reproducibility of lymphoscintigraphic drainage patterns in sequential 99mTc human serum albumin and 99mTc sulfur colloid studies: implications for sentinel node identification in melanoma. Surgery. 1999;126(5):955–962.
  • Rettenbacher L, Koller J, Kässmann H, Holzmannhofer J, Rettenbacher T, Galvan G. Reproducibility of lymphoscintigraphy in cutaneous melanoma: can we accurately detect the sentinel lymph node by expanding the tracer injection distance from the tumor site? J Nucl Med. 2001;42(3):424–429.
  • Uren RF, Howman-Giles R, Chung DK, Morton RL, Thompson JF. The reproducibility in routine clinical practice of sentinel lymph node identification by pre-operative lymphoscintigraphy in patients with cutaneous melanoma. Ann Surg Oncol. 2007;14(2):899–905.
  • Vidal M, Vidal-Sicart S, Torrents A, et al. Accuracy and reproducibility of lymphoscintigraphy for sentinel node detection in patients with cutaneous melanoma. J Nucl Med. 2012;53(8):1193–1199.
  • Vitali GC, Trifirò G, Zonta M, et al. Lymphoscintigraphy in clinical routine practice: reproducibility and accuracy in melanoma patients with a long-term follow-up. Eur J Surg Oncol. 2014;40(1):55–60.
  • Tanis PJ, Valdés Olmos RA, Muller SH, Nieweg OE. Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results. Radiology. 2003;228(2):546–551.
  • Kroon BK, Valdés Olmos RA, van Tinteren H, Nieweg OE, Horenblas S. Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma. J Urol. 2005;174(6):2214–2217.
  • Rubello D, Zavagno G, Bozza F, et al. Analysis of technical and clinical variables affecting sentinel node localization in patients with breast cancer after a single intradermal injection of 99mTc nanocolloidal albumin. Nucl Med Commun. 2004;25(11):1119–1124.
  • Alazraki N, Glass EC, Castronovo F, Olmos RA, Podoloff D; Society of Nuclear Medicine. Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0. J Nucl Med. 2002;43(10):1414–1418.
  • Mariani G, Erba P, Manca G, et al. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. J Surg Oncol. 2004;85(3):141–151.
  • Mariani G, Erba P, Villa G, et al. Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspective. J Surg Oncol. 2004;85(3):112–122.
  • Valdés Olmos RA, Rietbergen DD, Vidal-Sicart S, Manca G, Giammarile F, Mariani G. Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from “open and see” to “see and open”. Q J Nucl Med Mol Imaging. 2014;58(2):127–139.
  • Collarino A, Donswijk ML, van Driel WJ, Stokkel MP, Valdés Olmos RA. The use of SPECT/CT for anatomical mapping of lymphatic drainage in vulvar cancer: possible implications for the extent of inguinal lymph node dissection. Eur J Nucl Med Mol Imaging. 2015;42(13):2064–2071.
  • Chícharo de Freitas JR, KleinJan GH, van der Poel HG, et al. Utility of SPECT/CT scan for anatomical localization of pararectal and presacral sentinel nodes in prostate cancer. Rev Esp Med Nucl Imagen Mol. 2015;34(1):19–23.
  • Vidal-Sicart S, Brouwer OR, Valdés-Olmos RA. Evaluation of the sentinel lymph node combining SPECT/CT with the planar image and its importance for the surgical act. Rev Esp Med Nucl. 2011;30(5):331–337.
  • Vermeeren L, Valdés Olmos RA, Klop WM, Balm AJ, van den Brekel MW. A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med. 2010;51(5):700–703.
  • Zaknun JJ, Giammarile F, Olmos RA, Vidal-Sicart S, Mariani G. Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept. Eur J Nucl Med Mol Imaging. 2012;39(1):1–3.
  • Van Den Berg NS, Buckle T, Kleinjan GI, et al. Hybrid tracers for sentinel node biopsy. Q J Nucl Med Mol Imaging. 2014;58(2):193–206.
  • Frontado LM, Brouwer OR, van den Berg NS, et al. Added value of the hybrid tracer indocyanine green-99mTc-nanocolloid for sentinel node biopsy in a series of patients with different lymphatic drainage patterns. Rev Esp Med Nucl Imagen Mol. 2013;32(4):227–233.
  • Vidal-Sicart S, Rioja ME, Paredes P, Keshtgar MR, Valdés Olmos RA. Contribution of perioperative imaging to radioguided surgery. Q J Nucl Med Mol Imaging. 2014;58(2):140–160.
  • Qin Z, Hall DJ, Liss MA, et al. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J Biomed Opt. 2013;18(10):101315.
  • Qin Z, Hoh CK, Hall DJ, Vera DR. A tri-modal molecular imaging agent for sentinel lymph node mapping. Nucl Med Biol. 2015;42(12):917–922.
  • Liss MA, Farshchi-Heydari S, Qin Z, et al. Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging. J Nucl Med. 2014;55(9):1552–1556.
  • Liss MA, Stroup SP, Qin Z, et al. Robotic-assisted fluorescence sentinel lymph node mapping using multimodal image guidance in an animal model. Urology. 2014;84(4):982e9– 982e14.
  • Lin D, Franc BL, Kashani-Sabet M, Singer MI. Lymphatic drainage patterns of the head and neck: cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck. 2006;28(3):249–255.
  • Parrett BM, Kashani-Sabet M, Singer M, et al. Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma. Otolaryngol Head Neck Surg. 2012;147(4):699–706.
  • Roy JM, Whitfield RJ, Gill PG. Review of the role of sentinel node biopsy in cutaneous head and neck melanoma. ANZ J Surg. Epub 2015 Sep 11.
  • Kretschmer L, Bertsch HP, Zapf A, et al. Nodal basin recurrence after sentinel lymph node biopsy for melanoma: a retrospective multicenter study in 2653 patients. Medicine (Baltimore). 2015;94(36):e1433.
  • Ho AM, Avery R, Krupinski EA, Warneke J, Kuo PH. Predictive role of imaging in sentinel lymph node dissection for melanoma. Lymphology. 2014;47(3):134–141.
  • Luo S, Lobo AZ, Tanabe KK, et al. Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes. JAMA Surg. 2015;150(5):465–472.
  • Bennie G, Vorster M, Buscombe J, Sathekge M. The added value of a single-photon emission computed tomography-computed tomography in sentinel lymph node mapping in patients with breast cancer and malignant melanoma. World J Nucl Med. 2015;14(1):41–46.
  • Stoffels I, Boy C, Pöppel T, et al. Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma. JAMA. 2012;308(10):1007–1014.
  • Veenstra HJ, Vermeeren L, Olmos RA, Nieweg OE. The additional value of lymphatic mapping with routine SPECT/CT in unselected patients with clinically localized melanoma. Ann Surg Oncol. 2012;19(3):1018–1023.
  • Goyal A, Newcombe RG, Mansel RE, et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer. 2005;41(2):238–243.
  • Uren RF, Howman-Giles R, Renwick SB, Gillett D. Lymphatic mapping of the breast: locating the sentinel lymph nodes. World J Surg. 2001;25(6):789–793.
  • Hindié E, Groheux D, Brenot-Rossi I, Rubello D, Moretti JL, Espié M. The sentinel node procedure in breast cancer: nuclear medicine as the starting point. J Nucl Med. 2011;52(3):405–414.
  • Moncayo VM, Aarsvold JN, Grant SF, Bartley SC, Alazraki NP. Status of sentinel lymph node for breast cancer. Semin Nucl Med. 2013;43(4):281–293.
  • Estourgie SH, Nieweg OE, Olmos RA, Rutgers EJ, Kroon BB. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239(2):232–237.
  • Huang O, Wang L, Shen K, et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat. 2008;107(3):379–387.
  • Yao MS, Kurland BF, Smith AH, et al. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol. 2007;14(10):2985–2993.
  • Colleoni M, Zahrieh D, Gelber RD, et al. Site of primary tumor has a prognostic role in operable breast cancer: International Breast Cancer Study Group experience. J Clin Oncol. 2005;23(7):1390–1400.
  • Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: diagnosis and implications for patient management. A systematic review. J Clin Oncol. 2008;26(30):4981–4989.
  • Veronesi U, Arnone P, Veronesi P, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol. 2008;19(9):1553–1560.
  • Heuts EM, van der Ent FW, von Meyenfeldt MF, Voogd AC. Internal mammary lymph drainage and sentinel node biopsy in breast cancer – a study on 1008 patients. Eur J Surg Oncol. 2009;35(3):252–257.
  • Hindié E, Groheux D, Hennequin C, et al. Lymphoscintigraphy can select breast cancer patients for internal mammary chain radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(4):1081–1088.
  • Vermeeren L, Valdés Olmos RA, Meinhardt W, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate cancer. J Nucl Med. 2009;50(6):865–870.
  • Meinhardt W, van der Poel HG, Valdés Olmos RA, Bex A, Brouwer OR, Horenblas S. Laparoscopic sentinel lymph node biopsy for prostate cancer: the relevance of locations outside the ex-tended dissection area. Prostate Cancer. 2012;2012:751753.
  • Vermeeren L, Meinhardt W, van der Poel HG, Valdés Olmos RA. Lymphatic drainage from the treated versus untreated prostate: feasibility of sentinel node biopsy in recurrent cancer. Eur J Nucl Med Mol Imaging. 2010;37(11):2012–2026.
  • de Bonilla-Damiá A, Roberto Brouwer O, Meinhardt W, Valdés-Olmos RA. Lymphatic drainage in prostate carcinoma assessed by lymphoscintigraphy and SPECT/CT: its importance for the sentinel node procedure. Rev Esp Med Nucl Imagen Mol. 2012;31(2):66–70.
  • Valdés Olmos RA, Tanis PJ, Hoefnagel CA, et al. Penile lymphoscintigraphy for sentinel node identification. Eur J Nucl Med. 2001;28(5):581–585.
  • Leijte JA, Valdés Olmos RA, Nieweg OE, Horenblas S. Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection. Eur Urol. 2008;54(4):885–890.
  • Paño B, Sebastià C, Ripoll E, et al. Pathways of lymphatic spread in gynecologic malignancies. Radiographics. 2015;35(3):916–945.
  • Lindell G, Jonsson C, Ehrsson RJ, et al. Evaluation of preoperative lymphoscintigraphy and sentinel node procedure in vulvar cancer. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):91–95.
  • Martínez-Palones JM, Pérez-Benavente MA, Gil-Moreno A, et al. Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. Gynecol Oncol. 2006;103(3):865–870.
  • Klapdor R, Länger F, Gratz KF, Hillemanns P, Hertel H. SPECT/CT for SLN dissection in vulvar cancer: improved SLN detection and dissection by preoperative three-dimensional anatomical localisation. Gynecol Oncol. 2015;138(3):590–596.
  • Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30(31):3786–3791.
  • Van der Zee AG, Oonk MH, De Hulla JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26(6):884–889.
  • De Hullu JA, van der Zee AG. Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol. 2006;60(1):38–58.
  • Woelber L, Kock L, Gieseking F, et al. Clinical management of primary vulvar cancer. Eur J Cancer. 2011;47(15):2315–2321.
  • Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG)173. Gynecol Oncol. 2013;128(2):155–159.
  • Lécuru F, Mathevet P, Querleu D, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;29(13):1686–1691.
  • Bats AS, Frati A, Mathevet P, et al. Contribution of lymphoscintigraphy to intraoperative sentinel lymph node detection in early cervical cancer: analysis of the prospective multicenter SENTICOL cohort. Gynecol Oncol. 2015;137(2):264–269.
  • Klapdor R, Mücke J, Schneider M, et al. Value and advantages of preoperative sentinel lymph node imaging with SPECT/CT in cervical cancer. Int J Gynecol Cancer. 2014;24(2):295–302.
  • Hoogendam JP, Veldhuis WB, Hobbelink MG, Verheijen RH, van den Bosch MA, Zweemer RP. 99mTc SPECT/CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and metaanalysis. J Nucl Med. 2015;56(5):675–680.
  • Giammarile F, Bozkurt MF, Cibula D, et al. The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers. Eur J Nucl Med Mol Imaging. 2014;41(7):1463–1477.
  • Ballester M, Dubernard G, Lécuru F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12(5):469–476.
  • Frumovitz M, Bodurka DC, Broaddus RR, et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007;104(1):100–103.
  • Daraï E, Dubernard G, Bats AS, et al. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. Gynecol Oncol. 2015;136(1):54–59.
  • Sawicki S, Kobierski J, Lass P, Cytawa W, Wydra D. Preoperative detection of sentinel lymph nodes in endometrial cancer using SPECT/CT. Clin Nucl Med. 2013;38(9):726–729.
  • Naaman Y, Pinkas L, Roitman S, et al. The added value of SPECT/CT in sentinel lymph nodes mapping for endometrial carcinoma. Ann Surg Oncol. 2016;23(2):450–455.
  • Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Canc Netw. 2014;12(2):288–297.
  • Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. Epub 2015 Sep 4.
  • Cormier B, Rozenholc AT, Gotlieb W, et al; Communities of Practice (CoP) Group of Society of Gynecologic Oncology of Canada (GOC). Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization of future research. Gynecol Oncol. 2015;138(2):478–485.
  • Sawicki S, Lass P, Wydra D. Sentinel lymph node biopsy in endometrial cancer. Comparison of 2 detection methods. Int J Gynecol Cancer. 2015;25(6):1044–1050.
  • Niikura H, Kaiho Sakuma M, Tokunaga H, et al. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol. 2013;131(2):299–303.
  • Raimond E, Ballester M, Hudry D, et al. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study. Gynecol Oncol. 2014;133(3):506–511.
  • Cibula D, Oonk MH, Abu-Rustum NR. Sentinel lymph node biopsy in the management of gynecologic cancer. Curr Opin Obstet Gynecol. 2015;27(1):66–72.
  • Alkureishi LW, Ross GL, Shoaib T, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicentre trial. Ann Surg Oncol. 2010;17(9):2459–2464.
  • Pedersen NJ, Jensen HD, Hedbäck N, et al. Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: a retrospective single-center study of 253 consecutive patients. Head Neck. Epub 2015 Jun 3.
  • National Comprehensive Cancer Network [homepage on the Internet]. Available from: www.nccn.org. Accessed October 3, 2015.
  • Haerle SK, Hany TF, Strobel K, Sidler D, Stoeckli SJ. Is there an additional value of SPECT/CT over planar lymphoscintigraphy for sentinel node mapping in oral/oropharyngeal squamous cell carcinoma? Ann Surg Oncol. 2009;16(11):3118–3124.
  • Mayoral M, Paredes P, Sieira R, Vidal-Sicart S, Marti C, Pons F. The added value of a portable gamma camera for intraoperative detection of sentinel lymph node in squamous cell carcinoma of the oral cavity: a case report. Rev Esp Med Nucl Imagen Mol. 2014;33(4):237–240.
  • Hellingman D, de Wit-van der Veen LJ, Klop WM, Olmos RA. Detecting near-the-injection-site sentinel nodes in head and neck melanomas with a high-resolution portable gamma camera. Clin Nucl Med. 2015;40(1):e11–e16.